Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn’s Disease Patients with Prescription Claims for Ustekinumab in the USA

Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States

(2020) Camilo Obando et al.   ADVANCES IN THERAPY

Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice

(2020) Bo Ding et al.   International Journal of Chronic Obstructive Pulmonary Disease

Burden of Crohn’s disease in the United States: long-term healthcare and work-loss related costs

(2020) Ameur M. Manceur et al.   JOURNAL OF MEDICAL ECONOMICS

Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy

(2019) Chao Chen et al.   INFLAMMATORY BOWEL DISEASES

ACG Clinical Guideline: Management of Crohn’s Disease in Adults

(2018) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

P313 Steroid and opioid use among Crohn’s patients before and after initiation of ustekinumab

(2018) C Obando et al.   Journal of Crohns & Colitis

Infusion administration billing for vedolizumab and infliximab in inflammatory bowel disease

(2018) Kyle Null et al.   JOURNAL OF MEDICAL ECONOMICS

The Cost of Crohnʼs Disease

(2017) Bhavana B. Rao et al.   INFLAMMATORY BOWEL DISEASES

Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States

(2017) Haridarshan Patel et al.   PLoS One

Loss of Response to Anti-TNFs: Definition, Epidemiology and Management

(2016) Giulia Roda et al.   Clinical and Translational Gastroenterology

Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease

(2014) D. T. Rubin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Determinants of health-related quality of life in Crohn's disease: A systematic review and meta-analysis

(2013) Mike van der Have et al.   Journal of Crohns & Colitis

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population

(2012) Michael D. Kappelman et al.   DIGESTIVE DISEASES AND SCIENCES

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

(2012) Filip Baert et al.   Journal of Crohns & Colitis

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH